PT  - JOURNAL ARTICLE
AU  - Liza Darrous
AU  - Ninon Mounier
AU  - Zoltán Kutalik
TI  - Simultaneous estimation of bi-directional causal effects and heritable confounding from GWAS summary statistics
AID  - 10.1101/2020.01.27.20018929
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2020.01.27.20018929
4099  - http://medrxiv.org/content/early/2021/08/13/2020.01.27.20018929.short
4100  - http://medrxiv.org/content/early/2021/08/13/2020.01.27.20018929.full
AB  - Mendelian Randomisation (MR), an increasingly popular method that estimates the causal effects of risk factors on complex human traits, has seen several extensions that relax its basic assumptions. However, most of these extensions suffer from two major limitations; their under-exploitation of genome-wide markers, and sensitivity to the presence of a heritable confounder of the exposure-outcome relationship. To overcome these limitations, we propose a Latent Heritable Confounder MR (LHC-MR) method applicable to association summary statistics, which estimates bi-directional causal effects, direct heritabilities, and confounder effects while accounting for sample overlap. We demonstrate that LHC-MR out-performs several existing MR methods in a wide range of simulation settings and apply it to summary statistics of 13 complex traits. Besides several concordant results, LHC-MR unravelled new mechanisms (how being diagnosed for certain diseases might lead to improved lifestyle) and revealed new causal effects (e.g. HDL cholesterol being protective against high systolic blood pressure), hidden from standard MR methods due to a heritable confounder of opposite direction. Phenome-wide MR search suggested that the confounders indicated by LHC-MR for the birth weight-diabetes pair are likely to be obesity traits. Finally, LHC-MR results indicated that genetic correlations are predominantly driven by bi-directional causal effects and much less so by heritable confounders.Competing Interest StatementThe authors have declared no competing interest.Funding StatementZ.K. was funded by the Swiss National Science Foundation (31003A_169929, 310030_189147 and 32003B_173092).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe origin of the summary statistics data used is referenced in Table S1. UK Biobank summary statistics can be downloaded from http://www.nealelab.is/uk-biobank. CAD GWAS summary statistics data from http://www.cardiogramplusc4d.org/data-downloads http://www.nealelab.is/uk-biobank http://www.cardiogramplusc4d.org/data-downloads/